Please use this identifier to cite or link to this item: http://hdl.handle.net/2440/7709
Citations
Scopus Web of Science® Altmetric
?
?
Type: Journal article
Title: Iduronate-2-sulphatase protein detection in plasma from mucopolysaccharidosis type II patients
Author: Parkinson, E.
Muller, V.
Hopwood, J.
Brooks, D.
Citation: Molecular Genetics and Metabolism, 2004; 81(1):58-64
Publisher: Academic Press Inc Elsevier Science
Issue Date: 2004
ISSN: 1096-7192
1096-7206
Statement of
Responsibility: 
Emma J. Parkinson, Viv Muller, John J. Hopwood, and Doug A. Brooks
Abstract: The lysosomal storage disorder mucopolysaccharidosis type II (MPS II) is caused by a deficiency in the activity of the lysosomal exohydrolase iduronate-2-sulphatase (IDS). MPS II patients present within a spectrum of clinical phenotypes, which reflects the dynamic balance between the level of mutant protein, its residual enzyme activity and the resultant level of storage product. In this study, we have developed an immunoquantification assay for the accurate detection of iduronate-2-sulphatase protein and applied this methodology to the analysis of mutant iduronate-2-sulphatase protein in plasma samples from MPS II patients. The detection limit for the assay was defined as 20 ng/ml for wild type iduronate-2-sulphatase, but could be extended to a detection limit of 0.3 ng/ml by heat denaturation of the protein/plasma sample. The mutant protein detected in plasma from MPS II patients displayed similar properties to heat denatured wild type iduronate-2-sulphatase, suggesting an altered protein conformation. The ratio of heat denatured to native ELISA reactivity could be used to confirm the diagnosis of MPS II (i.e., a ratio of >1 for normal protein and <or=1 for mutant protein). Notably, four of the 20 patients tested had either normal or higher than normal levels of iduronate-2-sulphatase protein, but this protein also showed evidence of conformation change. The iduronate-2-sulphatase protein level detected in plasma from MPS II patients showed little or no direct correlation with the severity of the clinical phenotype observed in these patients.
Keywords: Lysosomal storage disorder; Mucopolysaccharidosis II; Iduronate-2-sulphatase; Mutant protein; Immunoquantification
Rights: © 2003 Elsevier Inc. All rights reserved.
RMID: 0020040004
DOI: 10.1016/j.ymgme.2003.11.002
Appears in Collections:Paediatrics publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.